Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001037463 | SCV001200877 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2019-02-20 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with asparagine at codon 835 of the LRBA protein (p.Ser835Asn). The serine residue is weakly conserved and there is a small physicochemical difference between serine and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with LRBA-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001037463 | SCV001525231 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2020-05-05 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Revvity Omics, |
RCV001037463 | SCV003817057 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2022-11-25 | criteria provided, single submitter | clinical testing |